Inhibition of ERK1/2 Worsens Intestinal Ischemia/Reperfusion Injury

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ban, Kechen ^a   Peng, Zhanglong ^a   Kozar, Rosemary A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; S6 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; MALE; MOLECULAR PATHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BUTADIENES; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION MEDIATORS; INTESTINAL DISEASES; LUNG DISEASES; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHOSPHORYLATION; REPERFUSION INJURY;

EID: 84884492180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076790     Document Type: Article

References (39)

1. Bellingan GJ, (2002) The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS. Thorax 57: 540-546. doi:10.1136/thorax.57.6.540. PubMed: 12037231.
2. Souza DG, Vieira AT, Soares AC, Pinho V, Nicoli JR, et al. (2004) The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 173: 4137-4146. PubMed: 15356164.
3. Tamion F, Richard V, Lyoumi S, Daveau M, Bonmarchand G, et al. (1997) Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol 273(2 Pt 1):: G314-G321. PubMed: 9277409.
4. Mallick IH, Yang W, Winslet MC, Seifalian AM, (2004) Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 49: 1359-1377. doi:10.1023/B:DDAS.0000042232.98927.91. PubMed: 15481305.
5. Cagnol S, Chambard JC, (2010) ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence. FEBS J 277: 2-21. doi:10.1111/j.1742-4658.2009.07366.x. PubMed: 19843174.
6. Gorelik G, Richardson B, (2010) Key role of ERK pathway signaling in lupus. Autoimmunity 43: 17-22. doi:10.3109/08916930903374832. PubMed: 19961364.
7. Mebratu Y, Tesfaigzi Y, (2009) How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle 8: 1168-1175. doi:10.4161/cc.8.8.8147. PubMed: 19282669.
8. Zhu YM, Wang CC, Chen L, Qian LB, Ma LL, et al. (2013) Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res 1494: 1-8. doi:10.1016/j.brainres.2012.11.047. PubMed: 23219579.
9. Wang H, Zhu QW, Ye P, Li ZB, Li Y, et al. (2012) Pioglitazone attenuates myocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2. Biosci Trends 6: 325-332. PubMed: 23337792.
10. Lu K, Liang CL, Liliang PC, Yang CH, Cho CL, et al. (2010) Inhibition of extracellular signal-regulated kinases 1/2 provides neuroprotection in spinal cord ischemia/reperfusion injury in rats: relationship with the nuclear factor-kappaB-regulated anti-apoptotic mechanisms. J Neurochem 114: 237-246. PubMed: 20403072.
11. Jeong S, Kim SJ, Jeong C, Lee S, Jeong H, et al. (2012) Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats. J Neurosurg Anesthesiol 24: 51-57. doi:10.1097/ANA.0b013e3182368d70. PubMed: 22015431.
12. Deng ZH Jr, Yan GT, Wang LH, Zhang JY, Xue H, et al. (2012) Leptin relieves intestinal ischemia/reperfusion injury by promoting ERK1/2 phosphorylation and the NO signaling pathway. J Trauma Acute Care Surg 72: 143-149. PubMed: 21857261.
13. Schalm SS, Blenis J, (2002) Identification of a conserved motif required for mTOR signaling. Curr Biol 12: 632-639. doi:10.1016/S0960-9822(02)00762-5. PubMed: 11967149.
14. Ban K, Kozar RA, (2012) Protective role of p70S6K in intestinal ischemia/reperfusion injury in mice. PLOS ONE 7: e41584. doi:10.1371/journal.pone.0041584. PubMed: 22848534.
15. Grishin A, Wang J, Hackam D, Qureshi F, Upperman J, et al. (2004) p38 MAP kinase mediates endotoxin-induced expression of cyclooxygenase-2 in enterocytes. Surgery 136: 329-335. doi:10.1016/j.surg.2004.05.008. PubMed: 15300199.
16. Yang R, Harada T, Li J, Uchiyama T, Han Y, et al. (2005) Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism. Intensive Care Med 31: 709-717. doi:10.1007/s00134-005-2601-9. PubMed: 15782315.
17. Alderliesten M, de Graauw M, Oldenampsen J, Qin Y, Pont C, et al. (2007) Extracellular signal-regulated kinase activation during renal ischemia/reperfusion mediates focal adhesion dissolution and renal injury. Am J Pathol 171: 452-462. doi:10.2353/ajpath.2007.060805. PubMed: 17620366.
18. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN, (1970) Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101: 478-483. doi:10.1001/archsurg.1970.01340280030009. PubMed: 5457245.
19. Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, et al. (2010) HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 299: G833-G843. doi:10.1152/ajpgi.00065.2010. PubMed: 20689059.
20. Wattanasirichaigoon S, Menconi MJ, Delude RL, Fink MP, (1999) Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. Shock 11: 269-275. doi:10.1097/00024382-199904000-00008. PubMed: 10220304.
21. Rocourt DV, Mehta VB, Besner GE, (2007) Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res 139: 269-273. doi:10.1016/j.jss.2006.10.047. PubMed: 17291530.
22. Martin DE, Hall MN, (2005) The expanding TOR signaling network. Curr Opin Cell Biol 17: 158-166. doi:10.1016/j.ceb.2005.02.008. PubMed: 15780592.
23. Sarbassov DD, Ali SM, Sabatini DM, (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17: 596-603. doi:10.1016/j.ceb.2005.09.009. PubMed: 16226444.
24. Petritsch C, Beug H, Balmain A, Oft M, (2000) TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 14: 3093-3101. doi:10.1101/gad.854200. PubMed: 11124802.
25. Delgoffe GM, Powell JD, (2009) mTOR: taking cues from the immune microenvironment. Immunology 127: 459-465. doi:10.1111/j.1365-2567.2009.03125.x. PubMed: 19604300.
26. Leseux L, Laurent G, Laurent C, Rigo M, Blanc A, et al. (2008) PKC zeta mTOR pathway: a new target for rituximab therapy in follicular lymphoma. Blood 111: 285-291. doi:10.1182/blood-2007-04-085092. PubMed: 17855629.
27. Yamnik RL, Holz MK, (2010) mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor alpha serine 167 phosphorylation. FEBS Lett 584: 124-128. doi:10.1016/j.febslet.2009.11.041. PubMed: 19925796.
28. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632. doi:10.1074/jbc.273.29.18623. PubMed: 9660836.
29. Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, et al. (2001) Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci U S A 98: 11569-11574. doi:10.1073/pnas.181213498. PubMed: 11504919.
30. Marampon F, Gravina GL, Di Rocco A, Bonfili P, Di Staso M, et al. (2011) MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals. Mol Cancer Ther 10: 159-168. doi:10.1158/1535-7163.MCT-10-0631. PubMed: 21220498.
31. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, et al. (2000) Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86: 692-699. doi:10.1161/01.RES.86.6.692. PubMed: 10747006.
32. Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, et al. (2004) MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109: 1938-1941. doi:10.1161/01.CIR.0000127126.73759.23. PubMed: 15096454.
33. Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC, (2009) ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 296: H1236-H1243. doi:10.1152/ajpheart.00100.2009. PubMed: 19286961.
34. Noh KT, Son KH, Jung ID, Kang HK, Hwang SA, et al. (2012) Protein kinase C δ (PKCδ)-extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascade regulates glycogen synthase kinase-3 (GSK-3) inhibition-mediated interleukin-10 (IL-10) expression in lipopolysaccharide (LPS)-induced endotoxemia. J Biol Chem 287: 14226-14233. doi:10.1074/jbc.M111.308841. PubMed: 22393041.
35. Rocker GM, (1997) Ischaemia/reperfusion, inflammatory responses and acute lung injury. Thorax 52: 841-842. doi:10.1136/thx.52.10.841. PubMed: 9404367.
36. Abraham E, (2003) Neutrophils and acute lung injury. Crit Care Med;31 (4 Suppl)():: S195-S199. doi:10.1097/00003246-200301000-00030. PubMed: 12682440.
37. Grommes J, Soehnlein O, (2011) Contribution of neutrophils to acute lung injury. Mol Med 17: 293-307. PubMed: 21046059.
38. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK, (1997) Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272: 5128-5132. doi:10.1074/jbc.272.8.5128. PubMed: 9030579.
39. Sato N, Moore FA, Kone BC, Zou L, Smith MA, et al. (2006) Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol 290: G616-G623. doi:10.1152/ajpgi.00248.2005. PubMed: 16257923.